Copyright Reports & Markets. All rights reserved.

Global Herpes Labialis Drugs Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Herpes Labialis Drugs Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Herpes Labialis Drugs Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Herpes Labialis Drugs Market Size Growth Rate by Type
    • 1.4.2 Valacyclovir
    • 1.4.3 Aciclovir
    • 1.4.4 Famciclovir
    • 1.4.5 Docosanol
    • 1.4.6 Other
  • 1.5 Market by Application
    • 1.5.1 Global Herpes Labialis Drugs Market Size Growth Rate by Application
    • 1.5.2 External Use
    • 1.5.3 Oral
    • 1.5.4 Injection
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Herpes Labialis Drugs Market Size, Estimates and Forecasts
    • 2.1.1 Global Herpes Labialis Drugs Revenue 2015-2026
    • 2.1.2 Global Herpes Labialis Drugs Sales 2015-2026
  • 2.2 Global Herpes Labialis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Herpes Labialis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Herpes Labialis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Herpes Labialis Drugs Competitor Landscape by Players

  • 3.1 Herpes Labialis Drugs Sales by Manufacturers
    • 3.1.1 Herpes Labialis Drugs Sales by Manufacturers (2015-2020)
    • 3.1.2 Herpes Labialis Drugs Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Herpes Labialis Drugs Revenue by Manufacturers
    • 3.2.1 Herpes Labialis Drugs Revenue by Manufacturers (2015-2020)
    • 3.2.2 Herpes Labialis Drugs Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Herpes Labialis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Herpes Labialis Drugs Revenue in 2019
    • 3.2.5 Global Herpes Labialis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Herpes Labialis Drugs Price by Manufacturers
  • 3.4 Herpes Labialis Drugs Manufacturing Base Distribution, Product Types
    • 3.4.1 Herpes Labialis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Herpes Labialis Drugs Product Type
    • 3.4.3 Date of International Manufacturers Enter into Herpes Labialis Drugs Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Herpes Labialis Drugs Market Size by Type (2015-2020)
    • 4.1.1 Global Herpes Labialis Drugs Sales by Type (2015-2020)
    • 4.1.2 Global Herpes Labialis Drugs Revenue by Type (2015-2020)
    • 4.1.3 Herpes Labialis Drugs Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Herpes Labialis Drugs Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Herpes Labialis Drugs Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Herpes Labialis Drugs Revenue Forecast by Type (2021-2026)
    • 4.2.3 Herpes Labialis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Herpes Labialis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Herpes Labialis Drugs Market Size by Application (2015-2020)
    • 5.1.1 Global Herpes Labialis Drugs Sales by Application (2015-2020)
    • 5.1.2 Global Herpes Labialis Drugs Revenue by Application (2015-2020)
    • 5.1.3 Herpes Labialis Drugs Price by Application (2015-2020)
  • 5.2 Herpes Labialis Drugs Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Herpes Labialis Drugs Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Herpes Labialis Drugs Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Herpes Labialis Drugs Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Herpes Labialis Drugs by Country
    • 6.1.1 North America Herpes Labialis Drugs Sales by Country
    • 6.1.2 North America Herpes Labialis Drugs Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Herpes Labialis Drugs Market Facts & Figures by Type
  • 6.3 North America Herpes Labialis Drugs Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Herpes Labialis Drugs by Country
    • 7.1.1 Europe Herpes Labialis Drugs Sales by Country
    • 7.1.2 Europe Herpes Labialis Drugs Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Herpes Labialis Drugs Market Facts & Figures by Type
  • 7.3 Europe Herpes Labialis Drugs Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Herpes Labialis Drugs by Region
    • 8.1.1 Asia Pacific Herpes Labialis Drugs Sales by Region
    • 8.1.2 Asia Pacific Herpes Labialis Drugs Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Herpes Labialis Drugs Market Facts & Figures by Type
  • 8.3 Asia Pacific Herpes Labialis Drugs Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Herpes Labialis Drugs by Country
    • 9.1.1 Latin America Herpes Labialis Drugs Sales by Country
    • 9.1.2 Latin America Herpes Labialis Drugs Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Herpes Labialis Drugs Market Facts & Figures by Type
  • 9.3 Central & South America Herpes Labialis Drugs Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Herpes Labialis Drugs by Country
    • 10.1.1 Middle East and Africa Herpes Labialis Drugs Sales by Country
    • 10.1.2 Middle East and Africa Herpes Labialis Drugs Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Herpes Labialis Drugs Market Facts & Figures by Type
  • 10.3 Middle East and Africa Herpes Labialis Drugs Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Herpes Labialis Drugs Products Offered
    • 11.1.5 GSK Related Developments
  • 11.2 Novartis
    • 11.2.1 Novartis Corporation Information
    • 11.2.2 Novartis Description and Business Overview
    • 11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Novartis Herpes Labialis Drugs Products Offered
    • 11.2.5 Novartis Related Developments
  • 11.3 Teva
    • 11.3.1 Teva Corporation Information
    • 11.3.2 Teva Description and Business Overview
    • 11.3.3 Teva Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Teva Herpes Labialis Drugs Products Offered
    • 11.3.5 Teva Related Developments
  • 11.4 Mylan
    • 11.4.1 Mylan Corporation Information
    • 11.4.2 Mylan Description and Business Overview
    • 11.4.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Mylan Herpes Labialis Drugs Products Offered
    • 11.4.5 Mylan Related Developments
  • 11.5 Cadila
    • 11.5.1 Cadila Corporation Information
    • 11.5.2 Cadila Description and Business Overview
    • 11.5.3 Cadila Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Cadila Herpes Labialis Drugs Products Offered
    • 11.5.5 Cadila Related Developments
  • 11.6 Apotex
    • 11.6.1 Apotex Corporation Information
    • 11.6.2 Apotex Description and Business Overview
    • 11.6.3 Apotex Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Apotex Herpes Labialis Drugs Products Offered
    • 11.6.5 Apotex Related Developments
  • 11.7 Daewoong Pharmaceutical
    • 11.7.1 Daewoong Pharmaceutical Corporation Information
    • 11.7.2 Daewoong Pharmaceutical Description and Business Overview
    • 11.7.3 Daewoong Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Daewoong Pharmaceutical Herpes Labialis Drugs Products Offered
    • 11.7.5 Daewoong Pharmaceutical Related Developments
  • 11.8 Livzon
    • 11.8.1 Livzon Corporation Information
    • 11.8.2 Livzon Description and Business Overview
    • 11.8.3 Livzon Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 Livzon Herpes Labialis Drugs Products Offered
    • 11.8.5 Livzon Related Developments
  • 11.9 Luoxin
    • 11.9.1 Luoxin Corporation Information
    • 11.9.2 Luoxin Description and Business Overview
    • 11.9.3 Luoxin Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Luoxin Herpes Labialis Drugs Products Offered
    • 11.9.5 Luoxin Related Developments
  • 11.10 Med shine
    • 11.10.1 Med shine Corporation Information
    • 11.10.2 Med shine Description and Business Overview
    • 11.10.3 Med shine Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Med shine Herpes Labialis Drugs Products Offered
    • 11.10.5 Med shine Related Developments
  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Description and Business Overview
    • 11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GSK Herpes Labialis Drugs Products Offered
    • 11.1.5 GSK Related Developments
  • 11.12 Blistex
    • 11.12.1 Blistex Corporation Information
    • 11.12.2 Blistex Description and Business Overview
    • 11.12.3 Blistex Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Blistex Products Offered
    • 11.12.5 Blistex Related Developments
  • 11.13 Kelun Group
    • 11.13.1 Kelun Group Corporation Information
    • 11.13.2 Kelun Group Description and Business Overview
    • 11.13.3 Kelun Group Sales, Revenue and Gross Margin (2015-2020)
    • 11.13.4 Kelun Group Products Offered
    • 11.13.5 Kelun Group Related Developments
  • 11.14 Hikma
    • 11.14.1 Hikma Corporation Information
    • 11.14.2 Hikma Description and Business Overview
    • 11.14.3 Hikma Sales, Revenue and Gross Margin (2015-2020)
    • 11.14.4 Hikma Products Offered
    • 11.14.5 Hikma Related Developments
  • 11.15 Haiwang
    • 11.15.1 Haiwang Corporation Information
    • 11.15.2 Haiwang Description and Business Overview
    • 11.15.3 Haiwang Sales, Revenue and Gross Margin (2015-2020)
    • 11.15.4 Haiwang Products Offered
    • 11.15.5 Haiwang Related Developments
  • 11.16 Carmex
    • 11.16.1 Carmex Corporation Information
    • 11.16.2 Carmex Description and Business Overview
    • 11.16.3 Carmex Sales, Revenue and Gross Margin (2015-2020)
    • 11.16.4 Carmex Products Offered
    • 11.16.5 Carmex Related Developments
  • 11.17 Cipher
    • 11.17.1 Cipher Corporation Information
    • 11.17.2 Cipher Description and Business Overview
    • 11.17.3 Cipher Sales, Revenue and Gross Margin (2015-2020)
    • 11.17.4 Cipher Products Offered
    • 11.17.5 Cipher Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Herpes Labialis Drugs Market Estimates and Projections by Region
    • 12.1.1 Global Herpes Labialis Drugs Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Herpes Labialis Drugs Revenue Forecast by Regions 2021-2026
  • 12.2 North America Herpes Labialis Drugs Market Size Forecast (2021-2026)
    • 12.2.1 North America: Herpes Labialis Drugs Sales Forecast (2021-2026)
    • 12.2.2 North America: Herpes Labialis Drugs Revenue Forecast (2021-2026)
    • 12.2.3 North America: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Herpes Labialis Drugs Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Herpes Labialis Drugs Sales Forecast (2021-2026)
    • 12.3.2 Europe: Herpes Labialis Drugs Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Herpes Labialis Drugs Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Herpes Labialis Drugs Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Herpes Labialis Drugs Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Herpes Labialis Drugs Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Herpes Labialis Drugs Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Herpes Labialis Drugs Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Herpes Labialis Drugs Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Herpes Labialis Drugs Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Herpes Labialis Drugs Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Herpes Labialis Drugs Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Herpes Labialis Drugs Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Herpes Labialis Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Herpes Labialis Drugs Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Herpes Labialis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Labialis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Herpes Labialis Drugs market is segmented into
    Valacyclovir
    Aciclovir
    Famciclovir
    Docosanol
    Other

    Segment by Application, the Herpes Labialis Drugs market is segmented into
    External Use
    Oral
    Injection

    Regional and Country-level Analysis
    The Herpes Labialis Drugs market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Herpes Labialis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Herpes Labialis Drugs Market Share Analysis
    Herpes Labialis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Herpes Labialis Drugs business, the date to enter into the Herpes Labialis Drugs market, Herpes Labialis Drugs product introduction, recent developments, etc.

    The major vendors covered:
    GSK
    Novartis
    Teva
    Mylan
    Cadila
    Apotex
    Daewoong Pharmaceutical
    Livzon
    Luoxin
    Med shine
    Bayer (Campho Phenique)
    Blistex
    Kelun Group
    Hikma
    Haiwang
    Carmex
    Cipher

    Buy now